Rapamycin preserves gut homeostasis during Drosophila aging

Oncotarget

Volumn 6, Issue 34, 2015, Pages 35274-35283

  Fan, Xiaolan ^a   Liang, Qing ^a   Lian, Ting ^a   Wu, Qi ^a   Gaur, Uma ^a   Li, Diyan ^a   Yang, Deying ^a   Mao, Xueping ^a   Jin, Zhihua ^b   Li, Ying ^a   Yang, Mingyao ^a  

^a SICHUAN AGRICULTURAL UNIVERSITY   (China)

^b ZHEJIANG UNIVERSITY   (China)

Author keywords

Aging; Drosophila; Gerotarget; Gut homeostasis; Intestinal stem cell; Rapamycin

Indexed keywords

MAMMALIAN TARGET OF RAPAMYCIN; RAPAMYCIN; TRANSCRIPTION FACTOR FOXO; TRANSCRIPTION FACTOR REL; ANTIINFECTIVE AGENT; DROSOPHILA PROTEIN; TARGET OF RAPAMYCIN KINASE;

ACETOBACTERACEAE; AGING; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; AUTOPHAGY; CELL PROLIFERATION; CONTROLLED STUDY; DROSOPHILA; DRUG EFFECT; ENTEROBACTERIACEAE; GUT HOMEOSTASIS; HOMEOSTASIS; INTESTINAL STEM CELL; INTESTINE EPITHELIUM; INTESTINE FLORA; INTESTINE FUNCTION DISORDER; INTESTINE PARAMETERS; LACTOBACILLUS; LIFE EXTENSION; NONHUMAN; UPREGULATION; AGE; ANIMAL; ANTAGONISTS AND INHIBITORS; CYTOLOGY; DRUG EFFECTS; FEMALE; INTESTINE; METABOLISM; RANDOMIZATION; SIGNAL TRANSDUCTION; STEM CELL;

AGE FACTORS; ANIMALS; ANTI-BACTERIAL AGENTS; CELL PROLIFERATION; DROSOPHILA; DROSOPHILA PROTEINS; FEMALE; HOMEOSTASIS; INTESTINES; RANDOM ALLOCATION; SIGNAL TRANSDUCTION; SIROLIMUS; STEM CELLS; TOR SERINE-THREONINE KINASES;

EID: 84946866922     PISSN: None     EISSN: 19492553     Source Type: Journal    
DOI: 10.18632/oncotarget.5895     Document Type: Article

References (41)

1. Bjedov I, Toivonen JM, Kerr F, Slack C, Jacobson J, Foley A and Partridge L. Mechanisms of life span extension by Rapamycin in the fruit fly Drosophila melanogaster. Cell metabolism. 2010; 11:35-46.
2. Slack C, Alic N, Foley A, Cabecinha M, Hoddinott MP and Partridge L. The Ras-Erk-ETS-Signaling Pathway Is a Drug Target for Longevity. Cell. 2015; 162:72-83.
3. Ewald CY, Landis JN, Porter Abate J, Murphy CT and Blackwell TK. Dauer-independent insulin/IGF-1-signalling implicates collagen remodelling in longevity. Nature. 2015; 519:97-101.
4. Nuzzo D, Picone P, Baldassano S, Caruana L, Messina E, Gammazza AM, Cappello F, Mule F and Di Carlo M. Insulin Resistance as Common Molecular Denominator Linking Obesity to Alzheimer's Disease. Current Alzheimer research. 2015; 12:723-35.
5. Anderson RM and Weindruch R. Calorie restriction: progress during mid-2005-mid-2006. Experimental gerontology. 2006; 41:1247-1249.
6. Longo VD, Antebi A, Bartke A, Barzilai N, Brown-Borg HM, Caruso C, Curiel TJ, de Cabo R, Franceschi C, Gems D, Ingram DK, Johnson TE, Kennedy BK, et al. Interventions to Slow Aging in Humans: Are We Ready? Aging cell. 2015; 14:497-510.
7. Rodriguez-Bies E, Navas P and Lopez-Lluch G. Agedependent effect of every-other-day feeding and aerobic exercise in ubiquinone levels and related antioxidant activities in mice muscle. The journals of gerontology Series A, Biological sciences and medical sciences. 2015; 70:33-43.
8. Lim HY, Bodmer R and Perrin L. Drosophila aging 2005/06. Experimental gerontology. 2006; 41:1213-1216.
9. Moyse E, Lahousse L and Krantic S. Current research in aging: a report from the 2015 Ageing Summit. Neurodegenerative disease management. 2015; 5:187-190.
10. Vijg J and Campisi J. Puzzles, promises and a cure for ageing. Nature. 2008; 454:1065-1071.
11. Guarente L and Kenyon C. Genetic pathways that regulate ageing in model organisms. Nature. 2000; 408:255-262.
12. Kenyon C. The plasticity of aging: insights from long-lived mutants. Cell. 2005; 120:449-460.
13. Biteau B, Karpac J, Supoyo S, Degennaro M, Lehmann R and Jasper H. Lifespan extension by preserving proliferative homeostasis in Drosophila. PLoS genetics. 2010; 6:e1001159.
14. Rera M, Clark RI and Walker DW. Intestinal barrier dysfunction links metabolic and inflammatory markers of aging to death in Drosophila. Proceedings of the National Academy of Sciences of the United States of America. 2012; 109:21528-21533.
15. Guo L, Karpac J, Tran SL and Jasper H. PGRP-SC2 promotes gut immune homeostasis to limit commensal dysbiosis and extend lifespan. Cell. 2014; 156:109-122.
16. Ohlstein B and Spradling A. The adult Drosophila posterior midgut is maintained by pluripotent stem cells. Nature. 2006; 439:470-474.
17. Radtke F, Clevers H and Riccio O. From gut homeostasis to cancer. Current molecular medicine. 2006; 6:275-289.
18. Ohlstein B and Spradling A. Multipotent Drosophila intestinal stem cells specify daughter cell fates by differential notch signaling. Science. 2007; 315:988-992.
19. Amcheslavsky A, Jiang J and Ip YT. Tissue damageinduced intestinal stem cell division in Drosophila. Cell Stem Cell. 2009; 4:49-61.
20. Buchon N, Broderick NA, Poidevin M, Pradervand S and Lemaitre B. Drosophila intestinal response to bacterial infection: activation of host defense and stem cell proliferation. Cell host & microbe. 2009; 5:200-211.
21. Jiang H, Patel PH, Kohlmaier A, Grenley MO, McEwen DG and Edgar BA. Cytokine/Jak/Stat signaling mediates regeneration and homeostasis in the Drosophila midgut. Cell. 2009; 137:1343-1355.
22. Biteau B, Hochmuth CE and Jasper H. JNK activity in somatic stem cells causes loss of tissue homeostasis in the aging Drosophila gut. Cell Stem Cell. 2008; 3:442-455.
23. Singh SR, Liu W and Hou SX. The adult Drosophila malpighian tubules are maintained by multipotent stem cells. Cell stem cell. 2007; 1:191-203.
24. Takashima S, Mkrtchyan M, Younossi-Hartenstein A, Merriam JR and Hartenstein V. The behaviour of Drosophila adult hindgut stem cells is controlled by Wnt and Hh signalling. Nature. 2008; 454:651-655.
25. Amcheslavsky A, Ito N, Jiang J and Ip YT. Tuberous sclerosis complex and Myc coordinate the growth and division of Drosophila intestinal stem cells. The Journal of cell biology. 2011; 193:695-710.
26. Quan Z, Sun P, Lin G and Xi R. TSC1/2 regulates intestinal stem cell maintenance and lineage differentiation through Rheb-TORC1-S6K but independently of nutritional status or Notch regulation. Journal of cell science. 2013; 126:3884-3892.
27. Kapuria S, Karpac J, Biteau B, Hwangbo D and Jasper H. Notch-mediated suppression of TSC2 expression regulates cell differentiation in the Drosophila intestinal stem cell lineage. PLoS genetics. 2012; 8:e1003045.
28. Emran S, Yang M, He X, Zandveld J and Piper MD. Target of Rapamycin signalling mediates the lifespan-extending effects of dietary restriction by essential amino acid alteration. Aging. 2014; 6:390-398.
29. Li Z, Zhang Y, Han L, Shi L and Lin X. Trachea-derived dpp controls adult midgut homeostasis in Drosophila. Developmental cell. 2013; 24:133-143.
30. Rera M, Bahadorani S, Cho J, Koehler CL, Ulgherait M, Hur JH, Ansari WS, Lo T, Jr., Jones DL and Walker DW. Modulation of longevity and tissue homeostasis by the Drosophila PGC-1 homolog. Cell metabolism. 2011; 14:623-634.
31. Choi NH, Kim JG, Yang DJ, Kim YS and Yoo MA. Agerelated changes in Drosophila midgut are associated with PVF2, a PDGF/VEGF-like growth factor. Aging cell. 2008; 7:318-334.
32. Abdelnour-Berchtold E, Cerantola Y, Roulin D, DormondMeuwly A, Demartines N and Dormond O. Rapamycinmediated FOXO1 inactivation reduces the anticancer efficacy of Rapamycin. Anticancer research. 2010; 30:799-804.
33. Becker T, Loch G, Beyer M, Zinke I, Aschenbrenner AC, Carrera P, Inhester T, Schultze JL and Hoch M. FOXOdependent regulation of innate immune homeostasis. Nature. 2010; 463:369-373.
34. Yang X, Smith AA, Williams MS and Pal U. A dityrosine network mediated by dual oxidase and peroxidase influences the persistence of Lyme disease pathogens within the vector. The Journal of biological chemistry. 2014; 289:12813-12822.
35. Shah OJ, Wang Z and Hunter T. Inappropriate activation of the TSC/Rheb/mTOR/S6K cassette induces IRS1/2 depletion, insulin resistance, and cell survival deficiencies. Current biology: CB. 2004; 14:1650-1656.
36. Huang S and Houghton PJ. Targeting mTOR signaling for cancer therapy. Current opinion in pharmacology. 2003; 3:371-377.
37. Lin JE, Snook AE, Li P, Stoecker BA, Kim GW, Magee MS, Garcia AV, Valentino MA, Hyslop T, Schulz S and Waldman SA. GUCY2C opposes systemic genotoxic tumorigenesis by regulating AKT-dependent intestinal barrier integrity. PloS one. 2012; 7:e31686.
38. Sandek A, Rauchhaus M, Anker SD and von Haehling S. The emerging role of the gut in chronic heart failure. Current opinion in clinical nutrition and metabolic care. 2008; 11:632-639.
39. Forsyth CB, Shannon KM, Kordower JH, Voigt RM, Shaikh M, Jaglin JA, Estes JD, Dodiya HB and Keshavarzian A. Increased intestinal permeability correlates with sigmoid mucosa alpha-synuclein staining and endotoxin exposure markers in early Parkinson's disease. PloS one. 2011; 6:e28032.
40. Giorgio V, Miele L, Principessa L, Ferretti F, Villa MP, Negro V, Grieco A, Alisi A and Nobili V. Intestinal permeability is increased in children with non-alcoholic fatty liver disease, and correlates with liver disease severity. Digestive and liver disease: official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver. 2014; 46:556-560.
41. Cheng J, Wei Z, Liu X, Li X, Yuan Z, Zheng J, Chen X, Xiao G and Li X. The role of intestinal mucosa injury induced by intra-abdominal hypertension in the development of abdominal compartment syndrome and multiple organ dysfunction syndrome. Critical care. 2013; 17:R283.